Latest AI and machine learning research in myeloma for healthcare professionals.
The unprecedented success of mRNA vaccines during the COVID-19 pandemic has accelerated the developm...
BACKGROUND AND OBJECTIVES: Multiple myeloma (MM) is characterized by substantial clinical heterogene...
This study aimed to assess the prognostic value of medullary total metabolic tumor volume (mTMTV) de...
BACKGROUND: Fat Mass and Obesity-Associated (FTO) is linked to multiple myeloma (MM) progression, bu...
Acinetobacter baumannii, particularly in its multidrug-resistant (MDR) and carbapenem-resistant (CRA...
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD), characterized by progressive cyst ...
BACKGROUND: Accurate differentiation of common hematologic disorders remains challenging in routine ...
Multiple myeloma (MM), long viewed as incurable, is entering a transformative era marked by deeper r...
BACKGROUND: The purpose of this study was to create a risk score for mortality within 3 years of ele...
Computer vision techniques have been increasingly used in livestock farming for tasks such as animal...
BACKGROUND: Machine learning (ML) algorithms are increasingly used in healthcare to support clinical...
Chimeric antigen receptor (CAR) T-cell therapy has transformed the management of hematologic maligna...
Multiple myeloma (MM) is recognized as a malignancy shaped by its complex tumor microenvironment (TM...
The FAD binding sites classification problem is crucial because it is directly related to many disea...
The expansion and potentiation of regulatory T cells (Treg cells) offer an appealing approach for ac...
DeepBrainNet, a machine learning tool, uses magnetic resonance imaging (MRI) to predict an individua...
DeepBrainNet, a machine learning tool, uses magnetic resonance imaging (MRI) to predict an individua...
Light chain amyloidosis (AL) and multiple myeloma (MM) are interrelated plasma cell disorders charac...